94. 原発性硬化性胆管炎 Primary sclerosing cholangitis Clinical trials / Disease details

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03678480 (ClinicalTrials.gov)	March 1, 2021	18/9/2018	A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)	A Phase 2, Randomized, Double-Blind Study of HTD1801vs Ursodeoxycholic Acid (UDCA) in Adolescents Wi ...	Primary Sclerosing Cholangitis;Cholangitis;Cholangitis, Sclerosing;Bile Duct Diseases;Biliary Tract ...	Drug: HTD1801;Drug: Ursodeoxycholic Acid	HighTide Biopharma Pty Ltd	NULL	Withdrawn	12 Years	17 Years	All	0	Phase 2	NULL
2	NCT03333928 (ClinicalTrials.gov)	February 9, 2018	27/10/2017	A POC and Dose-Ranging Study of HTD1801 in PSC Patients	A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801in Adult S ...	Primary Sclerosing Cholangitis (PSC)	Drug: HTD1801;Drug: Placebo	HighTide Biopharma Pty Ltd	NULL	Completed	18 Years	75 Years	All	59	Phase 2	United States;Canada
3	NCT03099603 (ClinicalTrials.gov)	March 24, 2017	14/3/2017	A Study of HTD1801 in Healthy Subjects	A First in Human, Randomized, Double-Blind Study to Assess Safety, Tolerability, and Pharmacokinetic ...	Primary Sclerosing Cholangitis	Drug: HTD1801	HighTide Biopharma Pty Ltd	NULL	Completed	18 Years	50 Years	All	32	Phase 1	Australia

First Previous1Next Last